IZAKOVIČOVÁ HOLLÁ, Lydie, Kateřina KAŇKOVÁ and Vladimír ZNOJIL. Haplotype analysis of the NADPH oxidase p22phox gene in patients with bronchial asthma. Int Arch Allergy Immunol. Basel: S Karger AG, 2009, vol. 148, No 1, p. 73-80. ISSN 1018-2438.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Haplotype analysis of the NADPH oxidase p22phox gene in patients with bronchial asthma
Name in Czech Haplotypová analýza genu pro NADPH oxidázy p22phox u pacientů s bronchiálním astmatem
Authors IZAKOVIČOVÁ HOLLÁ, Lydie (203 Czech Republic, guarantor), Kateřina KAŇKOVÁ (203 Czech Republic) and Vladimír ZNOJIL (203 Czech Republic).
Edition Int Arch Allergy Immunol, Basel, S Karger AG, 2009, 1018-2438.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.542
RIV identification code RIV/00216224:14110/09:00029064
Organization unit Faculty of Medicine
UT WoS 000261052800009
Keywords in English NADPH oxidase; p22phox; asthma; polymorphism; haplotype; gene
Tags asthma, gene, haplotype, NADPH oxidase, p22phox, polymorphism
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Lydie Izakovičová Hollá, Ph.D., učo 734. Changed: 17/6/2009 11:12.
Abstract
We sought to elucidate the role of genetic variability in the gene encoding p22phox subunit of the NADPH oxidase (CYBA, 16q24.3) in asthma susceptibility by means of association study of haplotypes based on three common single nucleotide polymorphisms (SNPs) -930A/G, 242C/T (H72Y) and 640A/G.
Abstract (in Czech)
V předložené práci studujeme úlohu genetické variability v genu kódujícím p22phox podjednotku NADPH oxidázy (CYBA, 16q24.3) ve vztahu k rozvoji astmatu pomocí asociační studie haplotypů tvořených třemi běžnými jednonukleotidovými polymorfizmy (SNPs) - 930A/G, 242C/T (H72Y) a 640A/G.
Links
GA310/06/0827, research and development projectName: Genetické determinanty pro-/antioxidační rovnováhy v patogeneze respiračních nemocí
Investor: Czech Science Foundation
PrintDisplayed: 30/4/2024 18:51